Atea Pharmaceuticals Inc (AVIR) — Cash Flow Quality Index

Latest as of December 2021: -0.64x

Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Quality Index of -0.64x as of December 2021. Operating cash flow of $-75.42 Million is below net income of $117.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Atea Pharmaceuticals Inc (AVIR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.64x

Operating CF / Net Income

Operating Cash Flow

$-75.42 Million

USD

Net Income

$117.13 Million

USD

Data as of

Dec 2021

Most recent filing

Atea Pharmaceuticals Inc Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Atea Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Atea Pharmaceuticals Inc (AVIR) cash conversion ratio.

Annual Cash Flow Quality Index for Atea Pharmaceuticals Inc (2021–2021)

Year-by-year earnings quality comparison for Atea Pharmaceuticals Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2021	-0.72x	$-87.00 Million	$121.19 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.